Loading clinical trials...

Aromatherapy Massage for Itching Management in Liver Diseases | Clinical Trials | Clareo Health

COMPLETEDNA

Aromatherapy Massage for Itching Management in Liver Diseases

The Effect of Aromatherapy Massage on Itching, Comfort, Skin pH Level, and Skin Moisture in Liver Diseases: Randomised Controlled Trial

NCT05367414•Amine Terzi

View on ClinicalTrials.gov

Summary

The aim of this study is to determine the effect of aromatherapy massage on itching, comfort, skin pH level and skin moisture in individuals with liver disease. Research Hypotheses: H1: Aromatherapy massage has an effect on the level of itching in individuals with itchy liver disease. H2: Aromatherapy massage has an effect on the general comfort level in individuals with itchy liver disease, H3: Aromatherapy massage has an effect on skin pH level in individuals with itchy liver disease. H4: Aromatherapy massage has an effect on skin moisture in individuals with itchy liver disease.

Detailed Description

This randomised controlled trial was conducted in order to examine study effect of aromatherapy massage on itching, comfort, skin pH level, and skin moisture among individuals with liver diseases

Eligibility

Age

37 - 88 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients who volunteered to participate in the study,
•with a diagnosis of chronic liver disease (liver cirrhosis (primary biliary cirrhosis, alcoholic, cardiac, post-necrotic, cryptogenic cirrhosis, Wilson's Cirrhosis, hemochromatosis), chronic viral hepatitis),
•had no cognitive impairment,
•were not included in the pre-application,
•could answer questions,
•itch score of above 3 (with Visual Analogue Scale).

Exclusion Criteria

•patients are taking antipruritic treatment,
•have itchy skin disease before, ulcer, eczema, etc. in the area to be applied
•patients with dermatological problems, any swelling or signs of inflammation in the area ---to be treated, neuropathy or loss of sensation in the area to be treated
•patients with allergic to tea tree oil, perfume, or cosmetics,
•diagnosed with cancer

Locations (1)

Artvin Coruh University

Artvin, Turkey (Türkiye)

Key Dates

Start Date

February 13, 2020

Primary Completion Date

May 3, 2021

Completion Date

June 23, 2021

Last Updated

January 29, 2025

Enrollment

ACTUAL participants

Conditions

AromatherapyMassageLiver DiseasesItchingpH LevelSkin Moisture

Interventions

aromatherapy massage (diluted tea tree oil)

OTHER

aromatherapy massage (sweet almond oil)

OTHER

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

NCT05264051

Liver Diseases

View study

RECRUITINGNA

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

NCT06493773

Liver Diseases, AlcoholicAlcohol Use Disorder+3 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Aromatherapy Massage for Itching Management in Liver Diseases

Inclusion Criteria

Exclusion Criteria

MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease

Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Aromatherapy Applied to Intensive Care Nurses Effect on Fatigue and Sleep Quality

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Design and Implementation of the Pediatric Liver Transplantation Biobank